Approvals/TGA/CIPLA IPRATROPIUM ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler

Approved

STANDARD

CIPLA IPRATROPIUM ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f4e1fbb85e44c54b
Product Name: CIPLA IPRATROPIUM ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Artg Id: 410010
Artg Name: CIPLA IPRATROPIUM ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2025-05-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/cf88db2fa866b2d69958b90291dfa0dc.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7e36b9bebee46218e2f8f6d93c248be7.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Jun 3, 2025

Approval ID

f4e1fbb85e44c54b

Type

Standard